NXTC - NextCure, Inc.

QQQ $ 454.82 $ -0.01 (-0 %)

DIA $ 398.57 $ 5.83 (1.53 %)

SPY $ 530.36 $ 4.59 (0.88 %)

TLT $ 91.26 $ 0.69 (0.77 %)

GLD $ 225.37 $ -1.23 (-0.57 %)

Previous Close

$ 1.54

Open

$ 1.59

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.56 - $ 1.59

52 Week Range

$ 0.98 - $ 2.57

Volume

54,306

Average Volume

Market Cap

44.09M

Beta (5Y Monthly)

$ 0.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	03-21-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-03-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-04-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-12-2019	06-30-2019	10-Q
21	06-10-2019	03-31-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Next...
05/31/2024 10:27:28

HC Wainwright & Co. analyst Emily Bodnar reiterates NextCure (NASDAQ:NXTC) with a Buy and maintains $8 price target.

NextCure To Present Phase 1b Data On NC410...
05/30/2024 20:43:46

Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease co...

HC Wainwright & Co. Reiterates Buy on Next...
05/03/2024 20:13:10

HC Wainwright & Co. analyst Emily Bodnar reiterates NextCure (NASDAQ:NXTC) with a Buy and maintains $8 price target.

Needham Reiterates Buy on NextCure, Mainta...
05/03/2024 20:05:13

Needham analyst Gil Blum reiterates NextCure (NASDAQ:NXTC) with a Buy and maintains $4 price target.

NextCure Q1 EPS $(0.61) Misses $(0.59) Est...
05/02/2024 21:09:21

NextCure (NASDAQ:NXTC) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.59) by...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/22/2024 21:33:05

HC Wainwright & Co. Maintains Buy on NextC...
03/22/2024 18:16:14

HC Wainwright & Co. analyst Emily Bodnar maintains NextCure (NASDAQ:NXTC) with a Buy and raises the price target from $5...

Needham Maintains Buy on NextCure, Maintai...
03/21/2024 18:59:57

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and maintains $4 price target.

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

NextCure Expects Its Existing Cash, Cash E...
03/21/2024 12:57:12

NextCure Reports FY23 EPS $(2.25) Vs $(2.6...
03/21/2024 12:56:54

Financial Results for Full Year Ended December 31, 2023Cash, cash equivalents, and marketable securities as of December 31, 202...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/06/2024 21:31:05

NextCure Publishes Preclinical Data Demons...
03/05/2024 13:07:26

12 Health Care Stocks Moving In Friday's A...
02/16/2024 21:31:07

NextCure Presents Preclinical Data Relatin...
01/18/2024 21:09:19

Nextcure Published Non-clinical Data Demon...
12/21/2023 12:07:06

why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Amtech Systems Shares Are Trading High...
12/14/2023 17:56:51

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

12 Health Care Stocks Moving In Thursday's...
12/14/2023 17:32:05

Needham Maintains Buy on NextCure, Lowers ...
12/14/2023 16:30:54

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $6 to $4.

us-stocks-higher-initial-jobless-claims-fall-to-202000

US Stocks Higher; Initial Jobless Claims F...
12/14/2023 14:40:47

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Th...